Primary Site >> Colorectal Cancer

Gene >> RPRM

Journal: Cancer Res. 2002 Jun 1;62(11):3024-9.
Title: p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.
Author: Zhang, Zhongqiu|Li, Jie|Lantry, Laura E|Wang, Yian|Wiseman, Roger W|Lubet, Ronald A|You, Ming
PMID: 12036908
Journal: Int J Cancer. 2005 Jul 1;115(4):503-10.
Title: Aberrant methylation of Reprimo in human malignancies.
Author: Takahashi, Takao|Suzuki, Makoto|Shigematsu, Hisayuki|Shivapurkar, Narayan|Echebiri, Chinyere|Nomura, Masaharu|Stastny, Victor|Augustus, Meena|Wu, Chew-Wun|Wistuba, Ignacio I|Meltzer, Stephen J|Gazdar, Adi F
PMID: 15700311
Journal: Int J Colorectal Dis. 2008 Apr;23(4):375-81.
Title: Reprimo 824 G>C and p53R2 4696 C>G single nucleotide polymorphisms and colorectal cancer: a case-control disease association study.
Author: Beasley, William D|Beynon, John|Jenkins, Gareth J S|Parry, Jim M
PMID: 18197409
Journal: Cell Death Discov. 2015;1.
Title: p53 Configures the G2/M Arrest Response of Nucleostemin-Deficient Cells.
Author: Huang, Guanqun|Meng, Lingjun|Tsai, Robert Y L
PMID: 26835157
Journal: Gut. 2018 Jul;67(7):1290-1298.
Title: Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.
Author: Chang, Wen-Chi L|Jackson, Christina|Riel, Stacy|Cooper, Harry S|Devarajan, Karthik|Hensley, Harvey H|Zhou, Yan|Vanderveer, Lisa A|Nguyen, Minhhuyen T|Clapper, Margie L
PMID: 29122850